Marinus Pharmaceuticals reported $-29130000 in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -45574000 15.21M
Amgen AMGN:US USD 3.04B 460M
Aptinyx Inc APTX:US USD -14557000 2.45M
Biogen BIIB:US USD 998.8M 6M
Eisai 4523:JP JPY 18.72B 11.02B
Enanta Pharmaceuticals ENTA:US USD -29502000 3.11M
Esperion Therapeutics ESPR:US USD -42421000 903K
Gilead Sciences GILD:US USD 2.7B 662M
Intercept Pharmaceuticals ICPT:US USD -17884000 7.82M
Intra Cellular Therapies ITCI:US USD -47225000 8.23M
Marinus Pharmaceuticals MRNS:US USD -29130000 811K
Minerva Neurosciences NERV:US USD -5063000 142K
Neurocrine Biosciences NBIX:US USD 107.8M 16M
Ptc Therapeutics PTCT:US USD -128092000 94.38M
Sarepta Therapeutics SRPT:US USD -96280000 24.37M
Supernus Pharmaceuticals SUPN:US USD 55.83M 35.58M
YTE INCY:US USD 111.58M 23.37M